21 May 2013
Keywords: poniard, starts, ph, oral, picoplatin, study, pharmaceuticals
Article | 23 April 2007
Poniard Pharmaceuticals, a US biopharmaceutical company focused on oncology, has announced treatment of the first patient in a Phase I
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 April 2007
20 May 2013
© 2013 thepharmaletter.com